DGAP-Adhoc: capsensixx AG: capsensixx AG sets the price for its initial offering at 16.00 EUR per share

NOT FOR PUBLICATION WITHIN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN.

capsensixx AG sets the price for its initial offering at 16.00 EUR per share.

Frankfurt, 11th June 2018 - capsensixx AG ("capsensixx"; with ISIN DE000A2G9M17), a leading provider of "Financial Administration as a Service", together with ICF BANK AG, who acts as Sole Coordinator and Sole Bookrunner to the transaction, set the price for its initial offering at EUR 16.00 per share. The listing is expected to take place on the 21st of June 2018 in the Prime Standard of the Frankfurter Wertpapierboerse.

Due to the initial offering 847,550 shares were placed, of which 330,000 are new shares subject to a capital increase of capsensixx AG. 407,000 shares are existing shares offered of PEH Wertpapier AG, the former single investor of capsensixx. 110,550 shares are subject to the Greenshoe option . The total placement amounts to about EUR 13.56 mill.

In total a maximum of 986,125 shares (incl. 128,625 Shares subject to the Greenshoe option), of which 330,000 new shares due to a capital increase and 527,500 of existing shares of the former sole shareholder PEH Wertpapier AG, were offered.

Including the Greenshoe the free-float is 24.7%. The market capitalisation of capsensixx AG amounts to EUR 54.88 mill., based on the set share price of EUR 16.00 per share.

The net proceeds of the offering are intended to fund the growth and expansion strategy of capsenixx's newly formated subsidiary coraixx.

For further information please contact:

Media Relations

edicto GmbH
Axel Mühlhaus/ Dr. Sönke Knop
Tel. +49(0) 69/905505-51
E-Mail: capsensixx@edicto.de

These materials are not for distribution, directly or indirectly, in or into the United States (including its territories and dependencies, any State of the United States and the District of Columbia), Australia, Canada or Japan. These materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for securities. The shares in capsensixx AG (the "Shares") mentioned herein may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "Securities Act"). The Shares have not been, and will not be, registered under the Securities Act and will not be offered or sold in the United States. There will be no public offering of securities in the United States or anywhere else outside of the Federal Republic of Germany and Luxembourg. The public offer in the Federal Republic of Germany and in Luxembourg will be made exclusively by means of and on the basis of a securities prospectus. The securities prospectus, subject to approval, will be published on the internet page of the Company.

In the United Kingdom, these materials are only being distributed to and are only directed at persons who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) (all such persons together being referred to as "Relevant Persons"). These materials are directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which these materials relate is available only to Relevant Persons and will be engaged in only with Relevant Persons.